Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Insulin_glulisine> ?p ?o. }
Showing items 1 to 58 of
58
with 100 items per page.
- Insulin_glulisine abstract "Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than human insulin. When used as a meal time insulin, the dose is given within 15 minutes before a meal or within 20 minutes after starting a meal. Intravenous injections may also be used for extreme hyperglycemia, but must be performed under the supervision of a medical professional.".
- Insulin_glulisine atcPrefix "A10".
- Insulin_glulisine atcSuffix "AB06".
- Insulin_glulisine casNumber "207748-29-6".
- Insulin_glulisine drugbank "DB01309".
- Insulin_glulisine fdaUniiCode "7XIY785AZD".
- Insulin_glulisine wikiPageExternalLink apidra.html.
- Insulin_glulisine wikiPageID "9756329".
- Insulin_glulisine wikiPageRevisionID "532446474".
- Insulin_glulisine atcPrefix "A10".
- Insulin_glulisine atcSuffix "AB06".
- Insulin_glulisine c "258".
- Insulin_glulisine casNumber "207748".
- Insulin_glulisine chemspiderid "NA".
- Insulin_glulisine drugbank "DB01309".
- Insulin_glulisine h "384".
- Insulin_glulisine hasPhotoCollection Insulin_glulisine.
- Insulin_glulisine kegg "D04540".
- Insulin_glulisine legalUk "POM".
- Insulin_glulisine legalUs "Rx-only".
- Insulin_glulisine medlineplus "a607033".
- Insulin_glulisine molecularWeight "5823".
- Insulin_glulisine n "64".
- Insulin_glulisine o "78".
- Insulin_glulisine pregnancyUs "C".
- Insulin_glulisine routesOfAdministration "Subcutaneous".
- Insulin_glulisine s "6".
- Insulin_glulisine tradename "Apidra".
- Insulin_glulisine unii "7".
- Insulin_glulisine verifiedfields "changed".
- Insulin_glulisine verifiedrevid "458271650".
- Insulin_glulisine watchedfields "changed".
- Insulin_glulisine subject Category:Insulin_therapies.
- Insulin_glulisine type Abstraction100002137.
- Insulin_glulisine type Act100030358.
- Insulin_glulisine type Activity100407535.
- Insulin_glulisine type Care100654885.
- Insulin_glulisine type Event100029378.
- Insulin_glulisine type InsulinTherapies.
- Insulin_glulisine type MedicalCare100657604.
- Insulin_glulisine type PsychologicalFeature100023100.
- Insulin_glulisine type Therapy100661091.
- Insulin_glulisine type Treatment100658082.
- Insulin_glulisine type Work100575741.
- Insulin_glulisine type YagoPermanentlyLocatedEntity.
- Insulin_glulisine type Drug.
- Insulin_glulisine type DrugProduct.
- Insulin_glulisine type FunctionalSubstance.
- Insulin_glulisine comment "Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than human insulin. When used as a meal time insulin, the dose is given within 15 minutes before a meal or within 20 minutes after starting a meal.".
- Insulin_glulisine label "Insulin glulisine".
- Insulin_glulisine sameAs m.02pr6x4.
- Insulin_glulisine sameAs Q6042242.
- Insulin_glulisine sameAs Q6042242.
- Insulin_glulisine sameAs insulin_glulisine.
- Insulin_glulisine sameAs DB01309.
- Insulin_glulisine sameAs Insulin_glulisine.
- Insulin_glulisine wasDerivedFrom Insulin_glulisine?oldid=532446474.
- Insulin_glulisine isPrimaryTopicOf Insulin_glulisine.